vs

Side-by-side financial comparison of COVENANT LOGISTICS GROUP, INC. (CVLG) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

COVENANT LOGISTICS GROUP, INC. is the larger business by last-quarter revenue ($307.2M vs $225.6M, roughly 1.4× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 1.4%, a 17.9% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 14.0%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 3.4%).

Covenant Logistics Group, Inc. is an American company focused on truckload shipping. The company is headquartered in Chattanooga, Tennessee, and is publicly traded on the New York Stock Exchange. The company provides temperature controlled trucking, regional delivery, and longhaul team driver delivery.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CVLG vs ORGO — Head-to-Head

Bigger by revenue
CVLG
CVLG
1.4× larger
CVLG
$307.2M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+64.1% gap
ORGO
78.1%
14.0%
CVLG
Higher net margin
ORGO
ORGO
17.9% more per $
ORGO
19.4%
1.4%
CVLG
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
3.4%
CVLG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CVLG
CVLG
ORGO
ORGO
Revenue
$307.2M
$225.6M
Net Profit
$4.4M
$43.7M
Gross Margin
Operating Margin
2.0%
28.1%
Net Margin
1.4%
19.4%
Revenue YoY
14.0%
78.1%
Net Profit YoY
-32.7%
469.5%
EPS (diluted)
$0.17
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVLG
CVLG
ORGO
ORGO
Q1 26
$307.2M
Q4 25
$295.4M
$225.6M
Q3 25
$296.9M
$150.9M
Q2 25
$302.9M
$101.0M
Q1 25
$269.4M
$86.7M
Q4 24
$277.3M
$126.7M
Q3 24
$287.9M
$115.2M
Q2 24
$287.5M
$130.2M
Net Profit
CVLG
CVLG
ORGO
ORGO
Q1 26
$4.4M
Q4 25
$43.7M
Q3 25
$9.1M
$21.6M
Q2 25
$9.8M
$-9.4M
Q1 25
$6.6M
$-18.8M
Q4 24
$7.7M
Q3 24
$13.0M
$12.3M
Q2 24
$12.2M
$-17.0M
Gross Margin
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
CVLG
CVLG
ORGO
ORGO
Q1 26
2.0%
Q4 25
-8.2%
28.1%
Q3 25
2.7%
13.7%
Q2 25
3.8%
-12.5%
Q1 25
2.8%
-30.9%
Q4 24
3.1%
8.1%
Q3 24
5.6%
5.4%
Q2 24
5.4%
-10.7%
Net Margin
CVLG
CVLG
ORGO
ORGO
Q1 26
1.4%
Q4 25
19.4%
Q3 25
3.1%
14.3%
Q2 25
3.2%
-9.3%
Q1 25
2.4%
-21.7%
Q4 24
6.1%
Q3 24
4.5%
10.7%
Q2 24
4.2%
-13.1%
EPS (diluted)
CVLG
CVLG
ORGO
ORGO
Q1 26
$0.17
Q4 25
$-0.68
$0.31
Q3 25
$0.35
$0.11
Q2 25
$0.36
$-0.10
Q1 25
$0.24
$-0.17
Q4 24
$0.25
$0.05
Q3 24
$0.47
$0.09
Q2 24
$0.44
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVLG
CVLG
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$407.6M
$300.1M
Total Assets
$1.0B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
$4.9M
$93.7M
Q3 25
$2.7M
$63.7M
Q2 25
$143.0K
$73.1M
Q1 25
$11.2M
$110.0M
Q4 24
$35.6M
$135.6M
Q3 24
$35.2M
$94.3M
Q2 24
$1.3M
$89.9M
Total Debt
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
$261.7M
Q3 25
$233.3M
Q2 25
$245.8M
Q1 25
$216.3M
Q4 24
$221.6M
Q3 24
$231.4M
$62.3M
Q2 24
$235.0M
$63.8M
Stockholders' Equity
CVLG
CVLG
ORGO
ORGO
Q1 26
$407.6M
Q4 25
$404.0M
$300.1M
Q3 25
$423.7M
$255.1M
Q2 25
$416.9M
$233.2M
Q1 25
$443.6M
$242.9M
Q4 24
$438.3M
$262.9M
Q3 24
$431.6M
$278.5M
Q2 24
$419.4M
$263.5M
Total Assets
CVLG
CVLG
ORGO
ORGO
Q1 26
$1.0B
Q4 25
$1.0B
$598.7M
Q3 25
$1.0B
$509.8M
Q2 25
$1.0B
$461.1M
Q1 25
$980.0M
$467.4M
Q4 24
$997.6M
$497.9M
Q3 24
$1.0B
$446.3M
Q2 24
$995.0M
$443.2M
Debt / Equity
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
0.65×
Q3 25
0.55×
Q2 25
0.59×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.54×
0.22×
Q2 24
0.56×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVLG
CVLG
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
$25.5M
$39.4M
Q3 25
$41.4M
$3.1M
Q2 25
$21.9M
$-32.9M
Q1 25
$24.8M
$-19.9M
Q4 24
$21.9M
$10.9M
Q3 24
$56.9M
$8.7M
Q2 24
$22.4M
$4.7M
Free Cash Flow
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
$-3.0M
$34.8M
Q3 25
$-7.8M
$844.0K
Q2 25
$-14.5M
$-36.5M
Q1 25
$-8.6M
$-23.6M
Q4 24
$464.0K
$7.6M
Q3 24
$24.3M
$6.1M
Q2 24
$-28.1M
$2.9M
FCF Margin
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
-1.0%
15.4%
Q3 25
-2.6%
0.6%
Q2 25
-4.8%
-36.1%
Q1 25
-3.2%
-27.2%
Q4 24
0.2%
6.0%
Q3 24
8.4%
5.3%
Q2 24
-9.8%
2.2%
Capex Intensity
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
9.7%
2.1%
Q3 25
16.6%
1.5%
Q2 25
12.0%
3.6%
Q1 25
12.4%
4.2%
Q4 24
7.7%
2.7%
Q3 24
11.3%
2.2%
Q2 24
17.6%
1.4%
Cash Conversion
CVLG
CVLG
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
4.55×
0.14×
Q2 25
2.23×
Q1 25
3.78×
Q4 24
1.43×
Q3 24
4.36×
0.71×
Q2 24
1.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVLG
CVLG

Freight revenue$281.9M92%
Other$25.2M8%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons